Next generation drug discovery is facilitated through a platform utilizing artificial intelligence to enhance both the discovery process and lead optimization, particularly targeting cancer immunotherapy. The platform employs virtual biological simulations to describe molecules, significantly reducing the time and cost associated with drug development while aiming to improve the efficacy of cancer treatments.